Tyrosine 759 of the cytokine receptor gp130 is involved in Listeria monocytogenes susceptibility

Genes and Immunity

Volumn 3, Issue 3, 2002, Pages 136-143

  Kamimura, D ^a   Fu, D ^a   Matsuda, Y ^b   Atsumi, T ^a   Ohtani, T ^a,d   Park, S J ^a   Ishihara, K ^a   Hirano, T ^a,c  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c RIKEN   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokine receptor; gp130; Interferon gamma; Listeria monocytogenes; Point mutation

Indexed keywords

CYTOKINE RECEPTOR; GAMMA INTERFERON; GLYCOPROTEIN GP 130; MESSENGER RNA; NITRIC OXIDE; PHENYLALANINE; PROTEIN TYROSINE PHOSPHATASE SHP 2; TYROSINE; IL6ST PROTEIN, MOUSE; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; PHOSPHOTRANSFERASE;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CHROMOSOME 13; CHROMOSOME 5; CHROMOSOME MAP; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE LOCUS; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; IN VITRO STUDY; LISTERIA MONOCYTOGENES; LISTERIOSIS; LIVER; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ANIMAL; C57BL MOUSE; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; TRANSGENIC MOUSE;

BACTERIA (MICROORGANISMS); LISTERIA; LISTERIA MONOCYTOGENES;

ANIMALS; ANTIGENS, CD; CHROMOSOME MAPPING; CYTOKINE RECEPTOR GP130; GENETIC PREDISPOSITION TO DISEASE; INTERFERON TYPE II; LISTERIA INFECTIONS; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PHOSPHORYLATION; PHOSPHOTRANSFERASES; POINT MUTATION; TYROSINE;

EID: 0036561322     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363825     Document Type: Article

References (32)

1. Teranishi T, Hirano T, Arima N, Onoue K. Human helper T cell factor(s) (ThF). II. Induction of IgG production in B lymphoblastoid cell lines and identification of T cell-replacing factor- (TRF) like factor(s). J Immunol 1982; 128: 1903-1908.
2. Hirano T, Yasukawa K, Harada H et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986; 324: 73-76.
3. Hirano T. Interleukin 6 and its receptor: ten years later. Int Rev Immunol 1998; 16: 249-284.
4. Hirano T, Nakajima K, Hibi M. Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev 1997; 8: 241-252.
5. Tanner JW, Chen W, Young RL, Longmore GD, Shaw AS. The conserved box 1 motif of cytokine receptors is required for association with JAK kinases. J Biol Chem 1995; 270: 6523-6530.
6. Hibi M, Murakami M, Saito M et al. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 1990; 63: 1149-1157.
7. Fukada T, Hibi M, Yamanaka Y et al. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 1996; 5: 449-460.
8. Takahashi-Tezuka M, Yoshida Y, Fukada T et al. Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase. Mol Cell Biol 1998; 18: 4109-4117.
9. Nishida K, Yoshida Y, Itoh M et al. Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors. Blood 1999; 93: 1809-1816.
10. Itoh M, Yoshida Y, Nishida K et al. Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokine-induced extracellular signal-regulated kinase mitogen- activated protein kinase activation. Mol Cell Biol 2000; 20: 3695-3704.
11. Nicholson SE, De Souza D, Fabri LJ et al. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2- binding site on the shared cytokine receptor subunit gp130. Proc Natl Acad Sci USA 2000; 97: 6493-6498.
12. Schmitz J, Weissenbach M, Haan S, Heinrich PC, Schaper F. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J Biol Chem 2000; 275: 12848-12856.
13. Yamanaka Y, Nakajima K, Fukada T, Hibi M, Hirano T. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO J 1996; 15: 1557-1565.
14. Ohtani T, Ishihara K, Atsumi T et al. Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. Immunity 2000; 12: 95-105.
15. Unanue ER. Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance. Curr Opin Immunol 1997; 9: 35-43.
16. Kopf M, Baumann H, Freer G et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994; 368: 339-342.
17. Dalrymple SA, Lucian LA, Slattery R et al. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect Immun 1995; 63: 2262-2268.
18. Dalrymple SA, Slattery R, Aud DM et al. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect Immun 1996; 64: 3231-3235.
19. Liu Z, Simpson RJ, Cheers C. Role of interleukin-6 in T-cell activation during primary and secondary infection with Listeria monocytogenes. Infect Immun 1995; 63: 2790-2792.
20. Betz UAK, Bloch W, van den Broek M et al. Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. J Exp Med 1998; 188: 1955-1965.
21. Boyartchuk VL, Broman KW, Mosher RE et al. Multigenic control of Listeria monocytogenes susceptibility in mice. Nat Genet 2001; 27: 259-260.
22. Rodriguez C, Grosgeorge J, Nguyen VC, Gaudray P, Theillet C. Human gp130 transducer chain gene (IL6ST) is localized to chromosome band 5q11 and possesses a pseudogene on chromosome band 17p11. Cytogenet Cell Genet 1995; 70: 64-67.
23. Cheers C, McKenzie IF. Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis. Infect Immun 1978; 19: 755-762.
24. Harty JT, Bevan MJ. Specific immunity to Listeria monocytogenes in the absence of IFN gamma. Immunity 1995; 3: 109-117.
25. Dai WJ, Bartens W, Kohler G et al. Impaired macrophage listericidal and cytokine activities are responsible for the rapid death of Listeria monocytogenes-infected IFN- gamma receptor-deficient mice. J Immunol 1997; 158: 5297-5304.
26. Lu B, Ebensperger C, Dembic Z et al. Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice. Proc Natl Acad Sci USA 1998; 95: 8233-8238.
27. Tanaka T, Akira S, Yoshida K et al. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 1995; 80: 353-361.
28. Almeida PF, Almeida RCC. A PCR protocol using inl gene as a target for specific detection of Listeria monocytogenes. Food Control 2000; 11: 97-101.
29. Nishibori T, Cooray K, Xiong H et al. Correlation between the presence of virulence-associated genes as determined by PCR and actual virulence to mice in various strains of Listeria spp. Microbiol Immunol 1995; 39: 343-349.
30. Tonouchi N, Oouchi N, Kashima N et al. High-level expression of human BSF-2/IL-6 cDNA in Escherichia coli using a new type of expression-preparation system. J Biochem (Tokyo) 1988; 104: 30-34.
31. Matsuda Y, Harada YN, Natsuume-Sakai S et al. Location of the mouse complement factor H gene (cfh) by FISH analysis and replication R-banding. Cytogenet Cell Genet 1992; 61: 282-285.
32. Matsuda Y, Chapman VM. Application of fluorescence in situ hybridization in genome analysis of the mouse. Electrophoresis 1995; 16: 261-272.